More stories
Exclusive: Therapists and Trialists from Lykos’ Phase 3 MDMA-Assisted Therapy Studies Push Back on...
Late last month, the Institute for Clinical and Economic Review (ICER) published its draft evidence report on Lykos Therapeutics’ MDMA-assisted psychotherapy (which it abbreviates...
Natural Medicine Advisory Bulletin 11: March & April 2024
Written by the Vicente LLP team as part of our Colorado Natural Medicine Health Act Tracker.***Editor’s note: This post covers the following happenings since...
Navigating Psychedelics Q&A: Essential Skills for Psychedelic Practitioners
We’re offering this exclusive, free online webinar, Navigating Psychedelics Q&A: Essential Skills for Psychedelic Practitioners with David Drapkin, LCSW. This live event, taking place...
Psychedelic Education: Insights, Advice, and Where to Start
In this episode, Kyle and Johanna catch up, interviewing each other about psychedelic education and what they’ve learned, the biggest challenges, and what advice...
The Ketamine Conundrum
What if there was a potentially life-saving drug that could relieve depression and PTSD but also, potentially, force frequent users to rush to the...
Pα+ Psychedelic Bulletin #162: EQUULUS Therapeutics Emerges from Stealth; Responses to ICER’s Draft Evidence...
Featured content in this Issue: Companies, organisations and drug candidates mentioned in this Bulletin: EQUULUS Therapeutics; EQL-101; EQL-201; Gilgamesh Pharmaceuticals; DemeRx; atai Life Sciences;...
Decolonization, Difficult Conversations, and the Challenge of Merging Spirituality and Science
In this episode, Joe interviews Philip Wolf: writer, member of Rolling Stone’s Culture Council, founder of Cultivating Spirits (the first company in the U.S....
Insights from the European Medicines Agency’s Psychedelics Workshop: A Pα+ Dispatch
On Tuesday the 16th and Wednesday the 17th of April, the European Medicines Agency (EMA) hosted a meeting in Amsterdam, “Multi-stakeholder workshop on psychedelics...
Self Awareness and Inner Work: Essential Skills for Psychedelic-Informed Practitioners
Join us for a free webinar on the importance of self-awareness for psychedelic practitioners. In this workshop, you will learn: This workshop is designed...
The Microdosing Effect: Connecting the Dots Between Anecdote and Evidence
In 2024, the discourse around the effects of microdosing psychedelics is deeply polarized. Positioned at opposite ends of the conversation are microdosing evangelists who...
Bicycle day Reflections, Quantum Mechanics, and the Value in Studying Philosophy to Understand Psychedelic...
In this episode, Joe and Kyle interview Lenny Gibson, Ph.D.: philosopher, Grof-certified Holotropic Breathwork® facilitator, 20-year professor of transpersonal psychology at Burlington College, and...
Pα+ Psychedelic Bulletin #161: Numinus Shifts Focus to US; Algernon Makes DMT for Stroke...
Featured content in this Issue: Companies, organisations and drug candidates mentioned in this Bulletin: Numinus Wellness; The Dales Report; Algernon Pharmaceuticals; AP-188; Seyltx; atai...
